{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:46:58Z","timestamp":1770418018422,"version":"3.49.0"},"reference-count":120,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T00:00:00Z","timestamp":1574899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia, Minist\u00e9rio da Educa\u00e7\u00e3o e da Ci\u00eancia","award":["FCT UID\/QUI\/00062\/2019"],"award-info":[{"award-number":["FCT UID\/QUI\/00062\/2019"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Cyclodextrins, since their discovery in the late 19th century, were mainly regarded as excipients. Nevertheless, developments in cyclodextrin research have shown that some of these hosts can capture and include biomolecules, highlighting fatty acids and cholesterol, which implies that they are not inert and that their action may be used in specific medicinal purposes. The present review, centered on literature reports from the year 2000 until the present day, presents a comprehensive description of the known biological activities of cyclodextrins and their implications for medicinal applications. The paper is divided into two main sections, one devoted to the properties and applications of cyclodextrins as active pharmaceutical ingredients in a variety of pathologies, from infectious ailments to cardiovascular dysfunctions and metabolic diseases. The second section is dedicated to the use of cyclodextrins in a range of biomedical technologies.<\/jats:p>","DOI":"10.3390\/biom9120801","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T10:54:10Z","timestamp":1574938450000},"page":"801","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":169,"title":["Cyclodextrins: Emerging Medicines of the New Millennium"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4460-970X","authenticated-orcid":false,"given":"Susana Santos","family":"Braga","sequence":"first","affiliation":[{"name":"QOPNA &amp; LAQV\/REQUIMTE. Chemistry Department, University of Aveiro, 3810-193 Aveiro, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"key":"ref_1","first-page":"69","article-title":"Sur la fermentation de la f\u00e9cule par l\u2019action du ferment butyrique","volume":"112","author":"Villiers","year":"1891","journal-title":"C. R. Acad. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1020412412907","article-title":"Structure of the \u03b2-Cyclodextrin\u00b7p-Hydroxybenzaldehyde Inclusion Complex in Aqueous Solution and in the Crystalline State","volume":"43","author":"Braga","year":"2002","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"10940","DOI":"10.1021\/cr500081p","article-title":"A History of Cyclodextrins","volume":"114","author":"Crini","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.bi.08.070139.000501","article-title":"Polysaccharides and lignin","volume":"8","author":"Freudenberg","year":"1939","journal-title":"Annu. Rev. Biochem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jlac.19355180107","article-title":"\u00dcber Schardingers Dextrine aus St\u00e4rke","volume":"518","author":"Freudenberg","year":"1935","journal-title":"Justus Liebigs Ann. Chem."},{"key":"ref_6","first-page":"464","article-title":"R\u00f6ntgenographische Untersuchungen an Schardinger-Dextrinen","volume":"3","author":"Borchert","year":"1948","journal-title":"Z. Naturforschg. B"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Cramer, F. (1954). Einschlussverbindungen (Inclusion Compounds), Springer-Verlag.","DOI":"10.1007\/978-3-642-49192-4"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/cr970022c","article-title":"Introduction and General Overview of Cyclodextrin Chemistry","volume":"98","author":"Szejtli","year":"1998","journal-title":"Chem. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.foodhyd.2016.11.014","article-title":"Physico-chemical characterization and evaluation of bio-efficacies of black pepper essential oil encapsulated in hydroxypropyl-beta-cyclodextrin","volume":"65","author":"Rakmai","year":"2017","journal-title":"Food Hydrocoll."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19476337.2017.1286523","article-title":"Encapsulation of yarrow essential oil in hydroxypropyl-beta-cyclodextrin: Physiochemical characterization and evaluation of bio-efficacies","volume":"15","author":"Rakmai","year":"2017","journal-title":"CYTA J. Food"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.indcrop.2017.10.027","article-title":"Antioxidant and antimicrobial properties of encapsulated guava leaf oil in hydroxypropyl-beta-cyclodextrin","volume":"111","author":"Rakmai","year":"2018","journal-title":"Ind. Crops Prod."},{"key":"ref_12","first-page":"3","article-title":"Safety evaluation of certain food additives (\u03b1-cyclodextrin-addendum)","volume":"54","author":"Kroes","year":"2006","journal-title":"WHO Food Addit. Ser."},{"key":"ref_13","first-page":"257","article-title":"Safety evaluation of certain food additives (\u03b2-cyclodextrin)","volume":"35","author":"Pollit","year":"1996","journal-title":"WHO Food Addit. Ser."},{"key":"ref_14","first-page":"969","article-title":"JEFCA 55th meeting. Safety evaluation of certain food additives and contaminants (\u03b3-cyclodextrin)","volume":"44","author":"Abbott","year":"2000","journal-title":"WHO Food Addit. Ser."},{"key":"ref_15","unstructured":"(2004). Agency Response Letter Gras notice GRN No. 155."},{"key":"ref_16","unstructured":"(2001). Agency Response Letter Gras notice GRN No. 74."},{"key":"ref_17","unstructured":"(2000). Agency Response Letter Gras notice GRN No. 46."},{"key":"ref_18","unstructured":"European Medicines Agency (2014). Background Review for Cyclodextrins Used as Excipients, EMA. Available online: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2014\/12\/WC500177936.pdf."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1248\/bpb1978.5.741","article-title":"Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro","volume":"5","author":"Irie","year":"1982","journal-title":"J. Pharm. Dyn."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1432-1033.1989.tb15171.x","article-title":"Differential effects of \u03b1-, \u03b2- and \u03b3-cyclodextrins on human erythrocytes","volume":"186","author":"Ohtani","year":"1989","journal-title":"Eur. J. Biochem."},{"key":"ref_21","first-page":"1","article-title":"The cyclodextrins: A review","volume":"10","author":"Nitalikar","year":"2012","journal-title":"J. Curr. Pharm. Res."},{"key":"ref_22","unstructured":"Szycher, M. (1991). Pharmaceutical Uses of Cyclodextrin Derivatives. High Performance Biomaterials, A Comprehensive Guide to Medical and Pharmaceutical Applications, Technomic."},{"key":"ref_23","unstructured":"(2019, August 05). Vaccine Excipients Summary. Excipients Included in U.S. Vaccines, by Vaccine, Available online: https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/appendices\/b\/excipient-table-2.pdf."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Szente, L., Singhal, A., Domokos, A., and Song, B. (2018). Cyclodextrins: Assessing the Impact of Cavity Size, Occupancy, and Substitutions on Cytotoxicity and Cholesterol Homeostasis. Molecules, 23.","DOI":"10.3390\/molecules23051228"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejps.2010.04.014","article-title":"Evaluation of the cytotoxicity of \u03b2-cyclodextrin derivatives: Evidence for the role of cholesterol extraction","volume":"40","author":"Kiss","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_26","unstructured":"(2019, September 17). Captisol. Available online: https:\/\/www.captisol.com\/technology\/history."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1021\/jm00111a055","article-title":"Potent Inhibitory Effect of a Series of Modified Cyclodextrin Sulfates (mCDS) on the Replication of HIV-1 in Vitro","volume":"34","author":"Moriya","year":"1991","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000163724","article-title":"Synthetic cyclodextrin derivatives inhibit HIV infection in vitro","volume":"60","author":"Weiner","year":"1992","journal-title":"Pathobiology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1021\/jm00063a018","article-title":"A New Candidate for an Anti-HIV-1 Agent: Modified Cyclodextrin Sulfate (mCDS71)","volume":"36","author":"Moriya","year":"1993","journal-title":"J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/095632029901000102","article-title":"Characterization of human immunodeficiency virus type 1 resistant to modified cyclodextrin sulphate (mCDS71) in vitro","volume":"10","author":"Mori","year":"1999","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1089\/088922201300343690","article-title":"Lipid Rafts and HIV Pathogenesis: Host Membrane Cholesterol Is Required for Infection by HIV Type 1","volume":"17","author":"Liao","year":"2001","journal-title":"Aids Res. Hum. Retrov."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10847-008-9510-9","article-title":"Study of the cholesterol extraction capacity of \u03b2-cyclodextrin and its derivatives, relationships with their effects on endothelial cell viability and on membrane models","volume":"63","author":"Castagne","year":"2009","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1089\/088922203322280900","article-title":"Lipid rafts and HIV pathogenesis: Virion-associated cholesterol is required for fusion and infection of susceptible cells","volume":"19","author":"Liao","year":"2003","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1128\/JVI.77.15.8237-8248.2003","article-title":"Cholesterol Depletion of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus with \u03b2-Cyclodextrin Inactivates and Permeabilizes the Virions: Evidence for Virion-Associated Lipid Rafts","volume":"77","author":"Graham","year":"2003","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1172\/JCI0213236","article-title":"Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent","volume":"109","author":"Khanna","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e00497-18","DOI":"10.1128\/mSphere.00497-18","article-title":"Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation","volume":"3","author":"Matassoli","year":"2018","journal-title":"mSphere"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1128\/JVI.02730-07","article-title":"Incomplete Protection against Simian Immunodeficiency Virus Vaginal Transmission in Rhesus Macaques by a Topical Antiviral Agent Revealed by Repeat Challenges","volume":"82","author":"Ambrose","year":"2008","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1128\/JVI.00835-07","article-title":"Lipid Raft Disruption by Cholesterol Depletion Enhances Influenza A Virus Budding from MDCK Cells","volume":"81","author":"Barman","year":"2007","journal-title":"J. Virol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12543","DOI":"10.1128\/JVI.77.23.12543-12551.2003","article-title":"Role for Influenza Virus Envelope Cholesterol in Virus Entry and Infection","volume":"77","author":"Sun","year":"2003","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Verma, D.K., Gupta, D., and Lal, S.K. (2018). Host Lipid Rafts Play a Major Role in Binding and Endocytosis of Influenza A Virus. Viruses, 10.","DOI":"10.3390\/v10110650"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejmech.2018.01.040","article-title":"Design, synthesis and biological evaluation of water-soluble per-O-methylated cyclodextrin-C60 conjugates as anti-influenza virus agents","volume":"146","author":"Zhu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biomaterials.2015.11.034","article-title":"Pentacyclic triterpenes grafted on CD cores to interfere with influenza virus entry: A dramatic multivalent effect","volume":"78","author":"Xiao","year":"2016","journal-title":"Biomaterials"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejmech.2017.03.087","article-title":"Inhibition of influenza virus infection by multivalent pentacyclic triterpene-functionalized per-O-methylated cyclodextrin conjugates","volume":"134","author":"Tian","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.4049\/jimmunol.1402027","article-title":"Hydroxypropyl-\u03b2-Cyclodextrin Spikes Local Inflammation That Induces Th2 Cell and T Follicular Helper Cell Responses to the Coadministered Antigen","volume":"194","author":"Onishi","year":"2015","journal-title":"J. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3389\/fimmu.2016.00435","article-title":"Induction of Dendritic Cell Maturation and Activation by a Potential Adjuvant, 2-Hydroxypropyl-\u03b2-Cyclodextrin","volume":"7","author":"Kim","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.vaccine.2016.04.001","article-title":"Intranasal hydroxypropyl-\u03b2-cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection","volume":"34","author":"Kusakabe","year":"2016","journal-title":"Vaccine"},{"key":"ref_47","unstructured":"(2019, August 02). A Phase 1 Study of Hydroxypropyl-beta-cyclodextrin(HP-beta-CyD)-adjuvanted Influenza Split Vaccine, Available online: https:\/\/rctportal.niph.go.jp\/en\/detail?trial_id=UMIN000028530."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1128\/JVI.00117-08","article-title":"Cholesterol Effectively Blocks Entry of Flavivirus","volume":"82","author":"Lee","year":"2008","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1099\/vir.0.015420-0","article-title":"Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains","volume":"91","author":"Mosso","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.virusres.2013.03.005","article-title":"Requirement of cholesterol in the viral envelope for dengue virus infection","volume":"174","author":"Carro","year":"2013","journal-title":"Virus. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1099\/jgv.0.000881","article-title":"The dengue virus non-structural protein 1 (NS1) is secreted from infected mosquito cells via a non-classical caveolin-1-dependent pathway","volume":"98","author":"Medina","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/jmv.25414","article-title":"The role of lipid rafts in cell entry of human metapneumovirus","volume":"91","author":"Chen","year":"2019","journal-title":"J. Med. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Tang, Q.P., Liu, P.F., Chen, M.Z., and Qin, Y.L. (2019). Virion-Associated Cholesterol Regulates the Infection of Human Parainfluenza Virus Type 3. Viruses, 11.","DOI":"10.3390\/v11050438"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Guo, H.C., Huang, M., Yuan, Q., Wei, Y.Q., Gao, Y., Mao, L.J., Gu, L.J., Tan, Y.W., Zhong, Y.X., and Liu, D.X. (2017). The Important Role of Lipid Raft-Mediated Attachment in the Infection of Cultured Cells by Coronavirus Infectious Bronchitis Virus Beaudette Strain. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0170123"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Wudiri, G.A., and Nicola, A.V. (2017). Cellular Cholesterol Facilitates the Post-entry Replication Cycle of Herpes Simplex Virus 1. J. Virol., 91.","DOI":"10.1128\/JVI.00445-17"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3389\/fmicb.2017.02383","article-title":"Herpes Simplex Virus 1 Envelope Cholesterol Facilitates Membrane Fusion","volume":"8","author":"Wudiri","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1099\/vir.0.82150-0","article-title":"Newcastle disease virus may enter cells by caveolae-mediated endocytosis","volume":"88","author":"Holguera","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bbamem.2011.12.004","article-title":"Cholesterol dependence of Newcastle Disease Virus entry","volume":"1818","author":"Holguera","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1128\/JVI.00486-07","article-title":"Cholesterol Dependence of Varicella-Zoster Virion Entry into Target Cells","volume":"81","author":"Hambleton","year":"2007","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1128\/JVI.00123-15","article-title":"Detergent-Resistant Membrane Association of NS2 and E2 during Hepatitis C Virus Replication","volume":"89","author":"Shanmugam","year":"2015","journal-title":"J. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s10620-018-5401-0","article-title":"Hepatitis C Virus Entry into Macrophages\/Monocytes Mainly Depends on the Phagocytosis of Macrophages","volume":"64","author":"Liu","year":"2019","journal-title":"Digest. Dis. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1016\/j.bmc.2012.07.029","article-title":"Conjugation of cyclodextrin with fullerene as a new class of HCV entry inhibitors","volume":"20","author":"Xiao","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10847-019-00885-y","article-title":"Treating an old disease with new tricks: Strategies based on host\u2013guest chemistry for leishmaniasis therapy","volume":"93","author":"Braga","year":"2019","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/AAC.05412-11","article-title":"Identification of New Antileishmanial Leads from Hits Obtained by High-Throughput Screening","volume":"56","author":"Zhu","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.molbiopara.2003.10.002","article-title":"Cholesterol is required for Leishmania donovani infection: Implications in leishmaniasis","volume":"133","author":"Pucadyil","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1462-5822.2006.00695.x","article-title":"Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages","volume":"8","author":"Gaur","year":"2006","journal-title":"Cell. Microbiol."},{"key":"ref_67","unstructured":"Chattopadhyay, A., and Madhubala, R. (2005). Method of Treating Leishmaniasis Using Methylbeta-cyclodextrin. (20050227944 A1), U.S. Patent."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1023\/A:1018551518610","article-title":"Saccharide anions as inhibitors of the malaria parasite","volume":"14","author":"Clark","year":"1997","journal-title":"Glycoconjugate J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bcp.2006.10.030","article-title":"Sulfated cyclodextrins inhibit the entry of Plasmodium into red blood cells Implications for malarial therapy","volume":"73","author":"Crandall","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"ref_70","first-page":"453","article-title":"In vitro activity on Cryptosporidium parvum oocyst of different drugs with recognized anticryptosporidial efficacy","volume":"155","author":"Pors","year":"2004","journal-title":"Revue M\u00e9d. V\u00e9t."},{"key":"ref_71","first-page":"1118","article-title":"Unexpected activity of \u03b2-cyclodextrin against experimental infection by Cryptosporidium parvum","volume":"85","year":"2000","journal-title":"J. Parasitol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0020-7519(01)00220-X","article-title":"Treatment with \u03b2-cyclodextrin of natural Cryptosporidium parvum infections in lambs under field conditions","volume":"31","year":"2001","journal-title":"Int. J. Parasitol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.vetpar.2003.12.012","article-title":"Efficacy of \u03b1-cyclodextrin against experimental cryptosporidiosis in neonatal goats","volume":"120","author":"Pors","year":"2004","journal-title":"Vet. Parasitol."},{"key":"ref_74","unstructured":"Ramirez, F.G. (2015). Cyclodextrin Inclusion of Nutraceuticals, from the Bench to your Table. Cyclodextrins: Synthesis, Chemical Applications and Role in Drug Delivery, NovaSience. [1st ed.]. Chapter 6."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0891-5849(95)02173-6","article-title":"The role of oxidized lipoproteins in atherogenesis","volume":"20","author":"Berliner","year":"1996","journal-title":"Free Radic. Biol. Med."},{"key":"ref_76","first-page":"10771","article-title":"Hydroxy-propyl-beta-cyclodextrin-mediated efflux of 7-ketocholesterol from macrophage foam cells","volume":"265","author":"Kritharides","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_77","first-page":"11","article-title":"Cyclodextrins as potential human antiatherosclerotic agents. A comparative pilot study to determine the most optimum route of administration of Hydroxy-propyl-\u03b2-cyclodextrin (HP-\u03b2-CD) in the apolipoprotein-E deficient \u2018knockout\u2019 mouse: Part III. Determining the optimum concentration of oral HP-\u03b2-CD","volume":"10","author":"Martinic","year":"2011","journal-title":"Anim. Techol. Welfare"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"333ra50","DOI":"10.1126\/scitranslmed.aad6100","article-title":"Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming","volume":"8","author":"Zimmer","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.4049\/jimmunol.1700302","article-title":"Cyclodextrin Reduces Cholesterol Crystal\u2013Induced Inflammation by Modulating Complement Activation","volume":"199","author":"Bakke","year":"2017","journal-title":"J. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12944-016-0284-6","article-title":"Randomized double blind clinical trial on the effect of oral \u03b1-cyclodextrin on serum lipids","volume":"15","author":"Amar","year":"2016","journal-title":"Lipid. Health Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.kint.2018.06.031","article-title":"Hydroxypropyl-\u03b2-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis","volume":"94","author":"Mitrofanova","year":"2018","journal-title":"Kidney Int."},{"key":"ref_82","unstructured":"(2019, August 07). Variant Pharmaceuticals Completes Pre-IND Meeting with FDA on VAR 200 for Focal Segmental Glomerulosclerosis (FSGS), a Rare Kidney Disease. Available online: https:\/\/www.prnewswire.com\/news-releases\/variant-pharmaceuticals-completes-pre-ind-meeting-with-fda-on-var-200-for-focal-segmental-glomerulosclerosis-fsgs-a-rare-kidney-disease-300629892.html."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Aroora, P., and Dhingra, N. (2018). Use of 2-Hydroxypropyl-Beta-Cyclodextrin for Niemann-Pick Type C Disease. Cyclodextrin\u2014A Versatile Ingredient, IntechOpen. Chapter 4.","DOI":"10.5772\/intechopen.69187"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0024-3205(01)01384-4","article-title":"Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease","volume":"70","author":"Camargo","year":"2001","journal-title":"Life Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"9404","DOI":"10.1523\/JNEUROSCI.1317-11.2011","article-title":"Unesterified Cholesterol Accumulation in Late Endosomes\/Lysosomes Causes Neurodegeneration and Is Prevented by Driving Cholesterol Export from This Compartment","volume":"31","author":"Aqul","year":"2011","journal-title":"J. Neurosc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.ymgme.2010.11.148","article-title":"Intrathecal cyclodextrin therapy of feline Niemann-Pick Type C disease","volume":"102","author":"Vite","year":"2011","journal-title":"Mol. Gen. Metabol."},{"key":"ref_87","unstructured":"(2019, September 08). Orphanet, Orphan Designation\u2013USA. Available online: https:\/\/www.orpha.net\/consor\/cgi-bin\/Drugs_Search.php?lng=EN&data_id=88421&search=Drugs_Search_Simple&data_type=Status&Typ=Sub."},{"key":"ref_88","unstructured":"(2019, September 08). Orphan Designation EU\/3\/13\/1124. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/orphan-designations\/eu3131124."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(17)31465-4","article-title":"Intrathecal 2-hydroxypropyl-\u03b2-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: A non-randomised, open-label, phase 1\u20132 trial","volume":"390","author":"Ory","year":"2017","journal-title":"Lancet"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pediatrneurol.2017.12.014","article-title":"Long-Term Treatment of Niemann-Pick Type C1 Disease with Intrathecal 2-Hydroxypropyl-\u03b2-Cyclodextrin","volume":"80","author":"Chin","year":"2018","journal-title":"Pediatr. Neurol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40263-019-00642-2","article-title":"Long-Term Neuropsychological Outcomes from an Open-Label Phase I\/IIa Trial of 2-Hydroxypropyl-\u03b2-Cyclodextrins (VTS-270) in Niemann-Pick Disease, Type C1","volume":"33","author":"Farmer","year":"2019","journal-title":"CNS Drugs"},{"key":"ref_92","unstructured":"(2019, September 08). Clinicaltrials.Gov: Niemann-Pick Disease, Available online: https:\/\/clinicaltrials.gov\/search\/term=Niemann-Pick%20Disease."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s41419-018-1056-1","article-title":"Hydroxypropyl-beta and -gamma cyclodextrins rescue cholesterol accumulation in Niemann\u2013Pick C1 mutant cell via lysosome-associated membrane protein 1","volume":"9","author":"Singhal","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jclinane.2009.05.002","article-title":"Sugammadex: The first selective binding reversal agent for neuromuscular block","volume":"21","author":"Kovac","year":"2009","journal-title":"J. Clin. Anesth."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/1521-3757(20020118)114:2<275::AID-ANGE275>3.0.CO;2-A","article-title":"A Novel Concept of Reversing Neuromuscular Block: Chemical Encapsulation of Rocuronium Bromide by a Cyclodextrin-Based Synthetic Host","volume":"114","author":"Bom","year":"2002","journal-title":"Angew. Chem."},{"key":"ref_96","first-page":"51","article-title":"Multi-Faceted Initiative Designed to Improve Safety of Neuromuscular Blockade","volume":"30","author":"Chitilian","year":"2016","journal-title":"APSF Newsl."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/1658-354X.114063","article-title":"A survey of the current use of neuromuscular blocking drugs among the Middle Eastern anesthesiologists","volume":"7","author":"Eldawlatly","year":"2013","journal-title":"Saudi J. Anaesth."},{"key":"ref_98","first-page":"53","article-title":"The Development and Regulatory History of Sugammadex in the United States","volume":"30","author":"Murphy","year":"2016","journal-title":"APSF Newsl."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/EJA.0b013e32833d56b7","article-title":"Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: Results of a randomised, controlled trial","volume":"27","author":"Blobner","year":"2010","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4103\/0259-1162.123211","article-title":"Sugammadex: A revolutionary drug in neuromuscular pharmacology","volume":"7","author":"Singh","year":"2013","journal-title":"Anesth. Essays Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/0971-9784.69052","article-title":"Sugammadex: A short review and clinical recommendations for the cardiac anesthesiologist","volume":"13","author":"Hemmerling","year":"2010","journal-title":"Ann. Card. Anaesth."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/bja\/aet586","article-title":"Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg\u22121 for reversal of deep neuromuscular blockade in patients with severe renal impairment","volume":"114","author":"Panhuizen","year":"2015","journal-title":"Br. J. Anaesth."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cryobiol.2015.11.008","article-title":"Substitution of egg yolk by a cyclodextrin-cholesterol complex allows a reduction of the glycerol concentration into the freezing medium of equine sperm","volume":"72","author":"Blommaert","year":"2016","journal-title":"Cryobiology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.115.128553","article-title":"Cholesterol-Loaded Cyclodextrin Increases the Cholesterol Content of Goat Sperm to Improve Cold and Osmotic Resistance and Maintain Sperm Function after Cryopreservation","volume":"94","author":"Salmon","year":"2016","journal-title":"Biol. Reprod."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1017\/S1751731114000226","article-title":"Effect of cholesterol-loaded cyclodextrins on bull and goat sperm processed with fast or slow cryopreservation protocols","volume":"8","author":"Blanch","year":"2014","journal-title":"Animal"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5713\/ajas.2011.10141","article-title":"Effect of Cholesterol-loaded-cyclodextrin in Presence and Absence of Egg Yolk during Freezing Step on Quality of Markhoz Buck\u2019s Spermatozoa","volume":"24","author":"Farshad","year":"2011","journal-title":"Asian-Aust. J. Anim. Sci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"702","DOI":"10.14202\/vetworld.2014.702-706","article-title":"Cholesterol loaded cyclodextrin increases freezability of buffalo bull (Bubalus bubalis) spermatozoa by increasing cholesterol to phospholipid ratio","volume":"7","author":"Rajoriya","year":"2014","journal-title":"Vet. World"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.anireprosci.2015.06.006","article-title":"Effect of cholesterol-loaded-cyclodextrin on sperm viability and acrosome reaction in boar semen cryopreservation","volume":"159","author":"Lee","year":"2015","journal-title":"Anim. Reprod. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"12","DOI":"10.6000\/1927-520X.2014.03.01.3","article-title":"Effect of Methyl-B-Cyclodextrin (MBCD) on In Vitro Capacitation of Buffalo Frozen\/Thawed Sperm","volume":"3","author":"Elkhawagah","year":"2014","journal-title":"J. Buffalo Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40709-016-0043-x","article-title":"Effect of methyl-beta-cyclodextrin on the viability and acrosome damage of sex-sorted sperm in frozen-thawed bovine semen","volume":"23","author":"Lee","year":"2016","journal-title":"J. Biol. Res. Thessalon."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.anireprosci.2018.04.076","article-title":"Cyclodextrins or cholesterol-loaded-cyclodextrins? A better choice for improved cryosurvival of chicken spermatozoa","volume":"193","author":"Partyka","year":"2018","journal-title":"Anim. Reprod. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1017\/S0967199416000022","article-title":"Modification of membrane cholesterol and its impact on frozen\u2013thawed chicken sperm characteristics","volume":"24","author":"Partyka","year":"2016","journal-title":"Zygote"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4103\/0301-4738.100540","article-title":"Turning the tide of corneal blindness","volume":"60","author":"Oliva","year":"2012","journal-title":"Indian J. Ophthalmol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/ceo.12330","article-title":"Corneal blindness: A global problem","volume":"42","author":"Franzco","year":"2014","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Majumdar, S., Wang, X., Sommerfeld, S.D., Chae, J.J., Athanasopoulou, E.N., Shores, L.S., Duan, X., Amzel, L.M., Stellacci, F., and Schein, O. (2018). Cyclodextrin Modulated Type I Collagen Self-Assembly to Engineer Biomimetic Cornea Implants. Adv. Funct. Mater., 1804076.","DOI":"10.1002\/adfm.201804076"},{"key":"ref_116","first-page":"795","article-title":"Influence of cyclodextrins on the physical properties of collagen","volume":"4","author":"Chellam","year":"2013","journal-title":"Int. J. Pharma Bio Sci."},{"key":"ref_117","unstructured":"Elisseeff, J., Guo, Q., and Majumdar, S. (2015). Compositions Comprising Cyclodextrin Incorporated Collagen Matrices for Use in Biomedical Applications. (2015\/164733 Al), WO Patent."},{"key":"ref_118","unstructured":"Elisseeff, J., Guo, Q., Majumdar, S., and Singh, A. (2016). Cornea mimetic biomaterials: Vitrified collagen-cyclodextrin implants. (2016\/171745 Al), WO Patent."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.actbio.2018.06.033","article-title":"Incorporating \u03b2-cyclodextrin into collagen scaffolds to sequester growth factors and modulate mesenchymal stem cell activity","volume":"76","author":"Grier","year":"2018","journal-title":"Acta Biomater."},{"key":"ref_120","unstructured":"Pizzoni, A., and Pizzoni, P. (2015). Combination of Glycosaminoglycans and Cyclodextrins. (2015\/092516 Al), WO Patent."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/9\/12\/801\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:38:22Z","timestamp":1760189902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/9\/12\/801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,28]]},"references-count":120,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["biom9120801"],"URL":"https:\/\/doi.org\/10.3390\/biom9120801","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,28]]}}}